Track topics on Twitter Track topics that are important to you
Other equities analysts also recently issued reports about the stock. Citigroup Inc. downgraded shares of Teva Pharmaceutical Industries Limited from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $32.00 to $19.00 in a report on Wednesday.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...